Effects of combination of insulin and acarbose compared with insulin and gliclazide in type 2 diabetic patients

Acta Diabetologica

Volumn 36, Issue 1-2, 1999, Pages 93-97

  Guvener N ^a   Gedik, O ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Acarbose; Gliclazide; Insulin; Type 2 diabetes mellitus

Indexed keywords

ACARBOSE; ANTIDIABETIC AGENT; C PEPTIDE; CHOLESTEROL; GLICLAZIDE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; GLUCOSE BLOOD LEVEL; HUMAN; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ACARBOSE; BLOOD GLUCOSE; C-PEPTIDE; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; GLICLAZIDE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 0033139266     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005920050151     Document Type: Article

References (23)

1. Peters AL, Davidson MB (1991) Insulin plus sulfonylurea agent for treating type II diabetes. Ann Int Med 115:45-53
2. Zimmerman BR (1992) Preventing long term complications. Implications for combination therapy with acarbose. Drugs 44 [Suppl 3]:54-60
3. Bailey TS, Mezitis NHE (1990) Combination therapy with insulin and sulfonylureas for type II diabetes. Diabetes Care 13:687-695
4. Groop LC (1992) Sulfonylureas in NIDDM. Diabetes Care 15:737-754
5. Del Prato S (1991) Rationale for the association of sulfonylurea and insulin. Am J Med 90 [Suppl 6A]:77S-82S
6. Clissold SP, Edwards C (1988) Acarbose: A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 35:214-243
7. Chong PK, Jung RT, Rennie MJ, Scrimgeour CM (1995) Energy expenditure in type II diabetic patients on metformin and SU therapy. Diabet Med 12:401-408
8. Ikegami H, Fujisawa T, Rakugi H, Kumahara Y, Ogihara T (1997) Glucose tolerance and insulin resistance in the elderly. Nippon Ronen Igakkai Zasshi 34:365-368
9. Barnard RJ, Youngren JF, Martin DA (1995) Diet, not aging, causes skeletal muscle insulin resistance. Gerontology 41: 205-211
10. Barzilai N, Banerjee S, Hawkins M, Chang CJ, Chen W, Rosetti L (1998) The effect of age dependent increase in fat mass on peripheral insulin action is saturable. J Gerontol A Biol Sci Med Sci 53:B141-B146
11. Boden G, Chen X, Desantis RA, Kendrick Z (1993) Effects of age and body fat on insulin resistance in healthy men. Diabetes Care 16:728-733
12. Ferannini E, Natali A, Capaldo B, Lehtovirta M, Jacob S, Yki- Jarvinen H (1997) Insulin resistance, hyperinsulinemia and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR). Hypertension 30:1144-1149
13. Karhap AAP, Malkki M, Laakso M (1994) Isolated low HDL cholesterol: An insulin resistant state. Diabetes 43:411-417
14. Steinberger J, Moorehead C, Katch V, Rocchini AP (1995) Relationship between insulin resistance and abnormal lipid profile in obese adolescents. J Pediatr 126:690-695
15. Pugh JA, Wagner ML, Sawyer J, Ramirez G, Tuley M, Friedberg SJ (1992) Is combination sulfonylurea and insulin therapy useful in NIDDM patients? Ametaanalysis [see comments] Diabetes Care 15:953-959
16. Golay A, Guillet-Dauphinc N, Fendel A, Juge C, Assal JP (1995) The insulin-sparing effect of metformin in insulin-treated diabetic patients. Diabetes Metab Rev 11 [Suppl 1]:S63-S67
17. Peters AL, Davidson MB (1991) Insulin plus sulfonylurea agent for treating type 2 diabetes. Ann Intern Med 115:45-53
18. Scheen AJ, Castillo MJ, Lefebvre PJ (1993) Combination of oral antidiabetic drugs and insulin in the treatment of non-insulin dependent diabetes. Acta Clin Belg 48:259-268
19. Halimi S, Corticelli P, Benhamou PY (1991) Combination of insulin and sulfonylureas: a literature review. Am J Med 90 [Suppl 6A]:S83-S86
20. Groop LC, Groop PH, Stenman S (1990) Combined insulin-sulfonylurea therapy in treatment of NIDDM. Diabetes Care 13 [Suppl 3]:47-52
21. Gerard J, Luyckx A, Lefebvre P (1981) Improvement of metabolic control in insulin dependent diabetics treated with the glucosidase inhibitor acarbose for two months. Diabetologia 21:446-451
22. DeFronzo RA, Ferrannini E (1991) Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194
23. Lebovitz HE, Pasmantier R (1990) Combination insulin-sulfonylurea therapy. Diabetes Care 13:667-675